Home » Authors » Jennifer Boggs

Articles by Jennifer Boggs

Investors: Regulatory Rules Make Exit Paths Expensive

Sep. 23, 2005

By Jennifer Boggs

Investors: Regulatory Rules Make Exit Paths Expensive

Sep. 23, 2005

By Jennifer Boggs

Midwest Venture Conference Opens Today In Minneapolis

Sep. 21, 2005

By Jennifer Boggs

Axonyx Reports Expected' Miss With Phenserine In AD

Sep. 21, 2005

By Jennifer Boggs

Midwest Venture Conference Opens Today In Minneapolis

Sep. 21, 2005

By Jennifer Boggs

Axonyx Reports Expected' Miss With Phenserine In AD

Sep. 21, 2005

By Jennifer Boggs

Athenagen Raises $5.7M For New Angiogenesis Pathway

Sep. 20, 2005

By Jennifer Boggs

Athenagen Raises $5.7M For New Angiogenesis Pathway

Sep. 20, 2005

By Jennifer Boggs

Geron Brings In $72M For Telomerase Work, Trials

Sep. 19, 2005

By Jennifer Boggs

Geron Brings In $72M For Telomerase Work, Trials

Sep. 19, 2005

By Jennifer Boggs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 22, 2025
Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal
BioWorld
The J.P. Morgan (JPM) Healthcare Conference in San Francisco kicked off with a resounding bang as Johnson & Johnson (J&J) disclosed plans to acquire...
Proteomics study explores how protein changes influence disease
BioWorld Science
Fourteen global pharma companies are getting together to conduct the largest proteomics study to date, analyzing 600,000 blood samples held in the UK Biobank to...
Abbvie and Simcere enter a $1B T-cell engager deal
BioWorld Asia
Abbvie Inc. and Simcere Zaiming Pharmaceutical Co. Ltd. are part of the volley of large deals accompanying the opening of the 43rd annual J.P. Morgan Healthcare...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.